Sugerencias
Idioma
Información de la revista
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
796
Original Article
Acceso a texto completo
Pruebas no corregidas. Disponible online el 30 de octubre de 2026

Clinical and Dermoscopic Predictors of Invasiveness in Small-Diameter Melanomas (≤6mm): A Multicenter Study of 160 Cases

Visitas
796
A. Martín-Gorgojoa,b, T.-M. Capusanc,d, F.-J. Bru-Gorraizb, A.-P. Miguélezc, A. Comuniónb, M. Feitoa,e, C. Gómeze,f, I. Sánchez-Carpinteroa, M. Mayore, M.J. Beatog, A.-B. Enguitah, Y. Delgadoc, E. Daudénc, R. Ruiz-Rodrígueza, Á. Pizarroi,j,
Autor para correspondencia
angelpizarro84@gmail.com

Corresponding author.
a Department of Dermatology, Clínica Dermatológica Internacional, Madrid, Spain
b STI/Dermatology Department, Centro de Diagnóstico Médico-Madrid Salud, Madrid, Spain
c Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain
d Department of Dermatology, Hospital Universitario de Torrejón, Madrid, Spain
e Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain
f Department of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain
g Department of Pathology, Hospital Universitario La Paz, Madrid, Spain
h Pathology Unit, Clínica Dermatológica Internacional, Madrid, Spain
i Pigmented Lesions Unit, Clínica Dermatológica Internacional, Madrid, Spain
j Pigmented Lesions Unit, Instituto Madrileño de Oncología, Madrid, Spain
Ver más
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
fig0005
Tablas (6)
Table 1. Study methods, study groups, and variables assessed.
Tablas
Table 2. Demographic and epidemiological characteristics of the patients. Comparison of in situ and invasive melanomas (N=160).
Tablas
Table 3. Clinical characteristics of melanomas. Comparison of in situ and invasive melanomas (N=160).
Tablas
Table 4. Global dermoscopic risk features. Comparison of in situ and invasive melanomas (N=160).
Tablas
Table 5. Local dermoscopic risk features. Comparison of in situ and invasive melanomas (N=160).
Tablas
Table 6. Clinical circumstances when excision was decided. Comparison of in situ and invasive melanomas (N=160).
Tablas
Abstract
Background

Small-diameter melanomas (≤6mm) are increasingly diagnosed, but their recognition remains challenging because conventional clinical and dermoscopic criteria may be absent or subtle. We investigated their clinical and dermoscopic characteristics and associations with invasiveness.

Methods

This retrospective, multicenter observational study included 160 histologically confirmed primary cutaneous melanomas measuring ≤6mm, excised between 1998 and 2018. Clinical features were assessed using the ABCDE rule adapted for small melanomas, and global and local dermoscopic characteristics were evaluated for associations with invasiveness.

Results

Of 160 melanomas, 92 (57.5%) were in situ and 68 (42.5%) were invasive. Only 48 lesions (30%) exhibited at least three ABCDE characteristics, and the overall ABCDE score was not associated with invasiveness. In contrast, invasiveness was significantly associated with multiple suspicious global or local dermoscopic features, more than two colors, peripheral globules, blue-white veil, regression, and polymorphous vessels. Digital dermoscopic surveillance was associated with a higher proportion of in situ melanomas.

Conclusions

A substantial proportion of small-diameter melanomas are already invasive despite limited clinical atypia. Although conventional ABCDE criteria and dermoscopy have diagnostic limitations, specific dermoscopic features and their accumulation may help identify potentially invasive lesions. Digital dermoscopic surveillance may facilitate detection at the in situ stage.

Keywords:
Melanoma
Dermoscopy
Early diagnosis
Early detection of cancer
Epidemiology
Observational study
Resumen
Introducción

Los diagnósticos de melanomas de pequeño diámetro están aumentando. Su reconocimiento clínico y dermatoscópico puede ser difícil y en un porcentaje relevante de casos ya son melanomas invasores. Este estudio describe las características epidemiológicas, clínicas y dermatoscópicas de melanomas con diámetro ≤6mm y analiza factores relacionados con su invasividad.

Material y métodos

Estudio observacional, retrospectivo y multicéntrico de una serie de melanomas con diámetro ≤6mm extirpados entre enero de 1998 y diciembre de 2018. Para su evaluación clínica se empleó la regla ABCDE adaptada a melanomas pequeños y para su evaluación dermatoscópica se consideraron características globales y locales habitualmente descritas en melanoma.

Resultados

Se incluyeron 160 melanomas, 92 (57,5%) in situ y 68 (42,5%) invasores. Solo 48 lesiones (30%) mostraron 3 o más características ABCDE. La puntuación global en la regla ABCDE no se relacionó con la invasividad. La expresividad dermatoscópica se mostró también limitada en muchas de estas lesiones. La acumulación de características dermatoscópicas globales o locales sospechosas en una misma lesión sí se correlacionó con la invasividad, así como la presencia de más de dos colores, de glóbulos periféricos, de regresión gris, de velo azul blanquecino y de vasos polimorfos. El ámbito asistencial de sospecha se asoció con la invasividad destacando el mayor porcentaje de melanomas in situ en pacientes vigilados con dermatoscopia digital.

Conclusiones

Un porcentaje elevado de melanomas pequeños ya son invasores. Tanto la regla ABCDE clínica como la dermatoscopia muestran limitaciones para reconocer a muchas de estas lesiones como sospechosas.

Palabras clave:
Melanoma
Dermatoscopia
Diagnóstico precoz
Detección temprana de cáncer
Epidemiología
Estudio observacional
Texto completo
Introduction

Tumor thickness determines the prognosis and associated costs of melanoma.1 Early detection has been promoted by the ABCD mnemonic rule (1985),2 updated to ABCDE in 2004.3 Dermoscopy improves diagnostic sensitivity and specificity.4,5

Early detection has made it possible to identify increasingly thin and small melanomas.6,7 Those measuring ≤6mm account for up to one-third of cases in some series.8–11 The clinical diagnosis of small-diameter melanoma (SDM) can be challenging because these lesions may not meet several or any of the ABCDE criteria,12–14 beginning, by definition, with D (diameter). An adapted ABCDE rule has therefore been proposed for lesions ≤6mm, with D referring to dark (very dark pigmentation).15

Certain melanomas—particularly hypomelanotic or amelanotic,16 nodular,17 and SDM—pose a dermoscopic diagnostic challenge. Individual SDM cases in which dermoscopy was decisive have been reported.18,19 In a series of 206 pigmented lesions measuring<4mm, including 23 melanomas,20 dermoscopy increased diagnostic sensitivity. However, some authors have emphasized the limitations of dermoscopy in recognizing SDMs.11,21–24

Large SDM series with detailed dermoscopic assessments remain scarce. We identified only 13 publications comprising ≥20 cases,11,13,14,23–32 and the largest published series included 123 cases.32

The aim of this study was to analyze 160 SDMs from a multicenter series and correlate their characteristics with invasiveness.

Materials and methods

This retrospective, observational, descriptive, multicenter study included 160 primary cutaneous melanomas with a clinical diameter ≤6mm (measured on the skin or on the dermoscopic image before excision), for which clinical and dermoscopic images were available. Lesions were excised between 1998 and 2018 in Madrid (Hospital Universitario La Paz, Hospital Universitario La Princesa, Ayuntamiento de Madrid, Instituto Madrileño de Oncología, and Clínica Dermatológica Internacional). All diagnoses were confirmed histologically and reviewed by two expert dermatopathologists. Methodological details are presented in Table 1.

Table 1.

Study methods, study groups, and variables assessed.

Image acquisition  In 12 cases, contact dermoscopic images were obtained with immersion fluid and nonpolarized light using a Dermaphot® lens (Heine, Herrsching, Germany) attached to an analog camera. In the remaining 148 cases (92.5%), images were acquired by polarized contact dermoscopy using a DermLite Photo® lens attached to a digital camera (37 cases), a DermLite® dermoscope attached to a digital camera (28 cases), or videodermoscopy during digital dermoscopic follow-up (83 cases; see equipment below). 
Equipment used for digital dermoscopy  Patients assessed using systems combining total-body photography and digital dermoscopy were evaluated with one of three systems, depending on the equipment available at their follow-up center:Molemax II (Derma Instruments, Vienna, Austria), Molemax HD (Derma Medical Systems, Vienna, Austria), or FotoFinder (FotoFinder Systems, Teachscreen Software GmbH, Bad Birnbach, Germany). 
Study groups  In situ melanomas; Invasive melanomas. 
Clinical and demographic characteristics recorded  Age; Sex; Lesion diameter (1–4mm, 5–6mm).Note: There is neither consensus among authors nor a specific rationale for selecting particular thresholds to define small melanoma, or mini-/micromelanoma. Some publications include only melanomas<4mm. Dividing our series into 1–4mm and 5–6mm produced groups of 65 and 95 cases, respectively, allowing meaningful statistical and clinical comparisons.Location (anterolateral trunk, back, extremities excluding acral sites, and other locations including acral and facial lesions). 
Epidemiological melanoma risk characteristics recorded  Personal and family history of melanoma; >50 melanocytic nevi; >10 clinically atypical melanocytic nevi; History of a histologically confirmed dysplastic nevus; Meeting the criteria for familial atypical multiple mole melanoma syndrome (FAMMMS), as defined by Soura et al.33 
ABCDE assessment for small lesions  Available clinical images and medical records were reviewed for the presence or absence of the modified clinical ABCDE criteria for small melanomas (A, asymmetry; B, irregular border; C, color variation; D, very dark pigmentation; E, evolution).15 Two dermatologists experienced in diagnosing pigmented lesions evaluated each case; discrepancies were resolved by a third dermatologist specializing in early melanoma diagnosis.Lesions were grouped by the cumulative number of positive ABCDE features (0, 1–2, or 3–5), classified respectively as clinically nonatypical (0), mildly to moderately atypical (1–2), and markedly atypical (3–5). 
Suspicious global and local dermoscopic melanoma features assessed (selected from earlier publications34–36)  Suspicious global features (requiring integrated assessment of the entire lesion or affecting its overall interpretation): asymmetry along two axes;> 2 colors (light brown, dark brown, red, white, black, gray, and blue); a high-risk global pattern (multicomponent, nonspecific, or starburst); peripheral globules of any distribution; and irregularly or focally distributed peripheral globules.The latter 2 were classified as global because the entire lesion periphery must be examined. They may indicate active SDM growth. A regular ring of peripheral globules is frequent in growing melanocytic nevi, but age and globule morphology may influence its significance as a suspicious marker.37,38Local dermoscopic risk structures: because the series included 15 head and neck melanomas (5 lentigo maligna and 2 invasive lentigo maligna melanomas, all on the head) and 5 acral melanomas (all in situ), suspicious local features also included asymmetric perifollicular pigmentation and annular-granular structures (head lesions) and the parallel ridge pattern (acral lesions).34,35Two dermatologists with >6 years of dermoscopic experience assessed each lesion; a third dermatologist with >15 years of experience adjudicated disagreements. 
Clinical circumstances at the time of excision  Whether excision was performed with or without prior suspicion of melanoma (yes/no).Setting in which the lesion was first identified as potentially concerning, following Duarte et al.39: (a) patient, family member, or nondermatologist before dermatological consultation (patient setting); (b) dermatologist without a pigmented-lesion subspecialty who did not use digital dermoscopy (general dermatology); or (c) a pigmented-lesion expert assessing and monitoring the patient with digital dermoscopy (digital dermoscopy).Availability of earlier total-body and dermoscopic images and whether they showed a new lesion, obvious macroscopic changes, or dermoscopic changes only. Whether excision was based on clinical findings alone, dermoscopic findings alone, or both. 

We assessed possible associations between lesion invasiveness (in situ vs invasive) and 3 groups of variables: patient history and characteristics; clinical and dermoscopic tumor features; and the clinical circumstances in which excision was indicated.

Chi-square or Fisher exact tests were used as appropriate, and odds ratios were calculated for selected variables. Statistical significance was set at P<.05. The study was approved by the Research Ethics Committee of Hospital Universitario La Princesa (No. 2760, minutes 06/2016).

Results

We analyzed a total of 160 cases in 151 patients (mean age, 47 years; range, 14–84 years): 144 patients had 1 melanoma, 5 had 2, and 2 had 3. Overall, 57.5% were in situ (including seven lentigo maligna melanomas) and 42.5% were invasive (median thickness, 0.43mm; interquartile range, 0.3–0.6mm). Only three lesions exceeded a Breslow thickness of 1mm (2 nodular melanomas measuring 3mm in diameter, with thicknesses of 1.1 and 2.5mm, respectively, and 1 superficial spreading melanoma with a Breslow thickness of 1.2mm). None showed ulceration, and only 5 showed mitoses, including the three thickest lesions (sentinel lymph node biopsies were negative; all three patients remain alive and recurrence-free after ≥10 years of follow-up).

Table 2 details the demographic and epidemiological characteristics of the patients. The most common factor associated with increased melanoma risk or difficulties in surveillance was the presence of >50 nevi (48.1% of cases). Overall, 30.6% of patients had none of these factors. Only age at diagnosis was associated with invasiveness, with invasive tumors more frequent in patients <40 years of age.

Table 2.

Demographic and epidemiological characteristics of the patients. Comparison of in situ and invasive melanomas (N=160).

Variable  Total  Invasores68 (42.5%)  In situ92 (57.5%)  P value 
Age
<40  66  36 (52.9%)  30 (32.6%)  .03 
40–60  60  21 (30.9%)  39 (42.4%)  .03 
>60  34  11 (16.2%)  23 (25.0%)  .03 
Sex
Male  69  25 (36.8%)  44 (47.8%)  .16 
Female  91  43 (63.2%)  48 (52.2%)  .16 
Personal history of melanoma
Yes  53  22 (32.4%)  31 (33.7%)  .86 
No  107  46 (67.6%)  61 (66.3%)  .86 
Family history of melanoma
Yes  21  8 (11.8%)  13 (14.1%)  .66 
No  139  60 (88.2%)  79 (85.9%)  .66 
>50 melanocytic nevi
Yes  77  28 (41.2%)  49 (53.3%)  .13 
No  83  40 (58.8%)  43 (46.7%)  .13 
>10 atypical melanocytic nevi
Yes  58  21 (30.9%)  37 (40.2%)  .22 
No  102  47 (69.1%)  55 (59.8%)  .22 
Personal history of dysplastic melanocytic nevi
Yes  66  24 (35.3%)  42 (45.6%)  .19 
No  94  44 (64.7%)  50 (54.4%)  .19 
Cumulative risk factors
0  49  25 (36.8%)  24 (26.1%)  .2289 
1  38  17 (25.0%)  21 (22.8%)  .2289 
>1  73  26 (38.2%)  47 (51.1%)  .2289 
Familial atypical multiple mole melanoma syndrome (FAMMMS)
Yes  10  4 (5.9%)  6 (6.5%)  .87 
No  150  64 (94.1%)  86 (93.5%)  .87 

Rightmost column: Chi-square P values (P<.05 shown in bold).

The clinical characteristics of melanomas are summarized in Table 3. Notably, 65 tumors measured ≤4mm (minimelanomas), of which 43% were already invasive. The extremities accounted for 51% of cases (excluding acral lesions), most frequently the lower extremities (34.4% of the series, not separately shown in the table). Of these 55 cases on the lower extremities, 75% occurred in women.

Table 3.

Clinical characteristics of melanomas. Comparison of in situ and invasive melanomas (N=160).

Variable  Total  Invasores68 (42.5%)  In situ92 (57.5%)  P value 
Diameter
5–6mm  95  40 (58.8%)  55 (59.8%)  .90 
1–4mm  65  28 (41.2%)  37 (40.2%)  .90 
Location
Anterolateral trunk  17  12 (17.7%)  5 (5.4%)  .04 
Back  41  18 (26.5%)  23 (25.0%)  .04 
Extremities (nonacral)  82  33 (48.5%)  49 (53.3%)  .04 
Other  20  5 (7.3%)  15 (16.3%)  .04 
Asymmetry (A)
Yes  73  29 (42.6%)  44 (47.8%)  .52 
No  87  39 (57.4%)  48 (52.2%)  .52 
Border (B)
Yes  35  22 (32.4%)  13 (14.1%)  .006 
No  125  46 (67.6%)  79 (85.9%)  .006 
Color (C)
Yes  72  34 (50.0%)  38 (41.3%)  .27 
No  88  34 (50.0%)  54 (64.7%)  .27 
Darkness (D)
Yes  57  26 (38.2%)  31 (33.7%)  .55 
No  103  42 (61.8%)  61 (66.3%)  .55 
Evolution (E)
Yes  54  30 (44.1%)  24 (26.1%)  .017 
No  106  38 (55.9%)  68 (73.9%)  .017 
ABCDE (number of cumulative features)
0+  38  16 (23.5%)  22 (23.9%)  .23 
1–2+  74  27 (39.7%)  47 (51.1%)  .23 
3–5+  48  25 (36.8%)  23 (25.0%)  .23 

A-L: anterolateral.

Rightmost column: chi-square P values (P<.05 shown in bold).

Regarding the number of ABCDE characteristics (Table 3), 24% had none (clinically nonatypical; Fig. 1A and C), 46% had 1 or 2 (mild-to-moderate atypia; Fig. 1E), and 30% had ≥3 (marked clinical atypia; Fig. 1G). Invasive melanomas were more common on the anterolateral trunk. Irregular borders (B) and changes observed by the patient (E) were significantly associated with invasiveness.

Fig. 1.

Clinical images (A, C, E, and G) and corresponding dermoscopic images (B, D, F, and H) of 4 small melanomas. (A) In situ melanoma on the thigh of a 49-year-old woman, with growth unnoticed by the patient and a clinically nonatypical appearance. (B) Poorly structured pigment network as the only relevant dermoscopic finding. (C) Nodular melanoma presenting as a 3-mm pink facial papule in a 65-year-old woman, meeting no ABCD criteria and measuring 2.5mm in thickness. (D) Focal polymorphous vessels on dermoscopy. (E) Superficial spreading melanoma on the back of a 33-year-old man, 0.5mm thick, with minimal clinical atypia and growth detected by total-body photographs. (F) Clearly suspicious dermoscopy showing asymmetry along two axes, an atypical network, and focal peripheral globules. (G) In situ melanoma on the leg of a 76-year-old woman with marked clinical atypia. (H) Highly suspicious dermoscopy, with marked asymmetry, irregular pigmentation, and areas of prominent atypical network.

No suspicious global dermoscopic feature occurred in >50% of cases (Table 4). The most common were asymmetry along two axes (49%) and >2 colors (48%). Invasiveness was significantly associated with >2 colors, peripheral globules irrespective of their distribution (Fig. 1F), and the accumulation of several suspicious global features within one lesion. Notably, all three melanomas displaying regularly distributed peripheral globules in a ring were invasive and occurred in patients aged 36, 39, and 54 years (Breslow thicknesses, 0.35, 0.4, and 0.3mm).

Table 4.

Global dermoscopic risk features. Comparison of in situ and invasive melanomas (N=160).

Variable  Total  Invasive68 (42.5%)  In situ92 (57.5%)  P value (Chi-square)  OR (95%CI) 
Asymmetry along 2 axes
Yes  79  35 (51.5%)  44 (47.8%)  .65  1.16 (0.62–2.17) 
No  81  33 (48.5%)  48 (52.2%)  .65  1.16 (0.62–2.17) 
>2 colors
Yes  77  41 (60.3%)  36 (39.1%)  .008  2.36 (1.24–4.49) 
No  83  27 (39.7%)  56 (60.9%)  .008  2.36 (1.24–4.49) 
High-risk pattern
Yes  52  25 (36.8%)  27 (29.3%)  .32  1.40 (0.72–2.73) 
No  108  43 (63.2%)  65 (70.7%)  .32  1.40 (0.72–2.73) 
Peripheral globules
Yes  50  27 (39.7%)  23 (25.0%)  .047  1.98 (1.003–3.89) 
No  110  41 (60.3%)  69 (75.0%)  .047  1.98 (1.003–3.89) 
Focal or irregular peripheral globules
Yes  47  24 (35.3%)  23 (25.0%)  .16  1.64 (0.82–3.25) 
No  113  44 (64.7%)  69 (75.0%)  .16  1.64 (0.82–3.25) 
Cumulative features
>2  36  23 (33.8%)  13 (14.1%)  .003  3.11 (1.43–6.72) 
0–2  124  45 (66.2%)  79 (85.9%)  .003  3.11 (1.43–6.72) 

Penultimate column: chi-square P values (P<.05 shown in bold).

Among local features (Table 5), irregular dots/globules (44%) and an atypical pigment network (38%) were most frequent (Fig. 1B, F, and H). A blue-white veil, regression, and polymorphous vessels (Fig. 1D), together with an increasing accumulation of suspicious local features in the same lesion, were significantly associated with invasiveness.

Table 5.

Local dermoscopic risk features. Comparison of in situ and invasive melanomas (N=160).

Variable  Total  Invasive68 (42.5%)  In situ92 (57.5%)  P value (Chi-square)  OR 
Irregular dots and globules
Yes  70  34 (50.0%)  36 (39.2%)  .17  1.56 (0.83–2.93) 
No  90  34 (50.0%)  56 (60.8%)  .17  1.56 (0.83–2.93) 
Atypical pigment network
Yes  61  31 (45.6%)  30 (32.6%)  .09  1.73 (0.91–3.30) 
No  99  37 (54.4%)  62 (67.4%)  .09  1.73 (0.91–3.30) 
Irregular projections
Yes  37  14 (20.6%)  23 (25.0%)  .51  0.78 (0.37–1.65) 
No  123  54 (79.4%)  69 (75.0%)  .51  0.78 (0.37–1.65) 
Irregular pigmentation
Yes  35  19 (27.9%)  16 (17.3%)  .11  1.84 (0.87–3.92) 
No  125  49 (72.1%)  76 (82.7%)  .11  1.84 (0.87–3.92) 
Erythema
Yes  26  14 (20.6%)  12 (13.0%)  .20  1.73 (0.74–4.02) 
No  134  54 (79.4%)  80 (87.0%)  .20  1.73 (0.74–4.02) 
Blue-white veil
Yes  22  16 (23.5%)  6 (6.5%)  .002  4.41 (1.62–11.98) 
No  138  52 (76.5%)  86 (93.5%)  .002  4.41 (1.62–11.98) 
Regression
Yes  19  14 (20.6%)  5 (5.4%)  .003  4.51 (1.54–13.23) 
No  141  54 (79.4%)  87 (94.6%)  .003  4.51 (1.54–13.23) 
Dotted vessels
Yes  16  7 (10.3%)  9 (9.8%)  .91  1.06 (0.37–3.00) 
No  144  61 (89.7%)  83 (90.2%)  .91  1.06 (0.37–3.00) 
Negative pigment network
Yes  8  3 (4.4%)  5 (5.4%)  .77  0.80 (0.19–3.48) 
No  152  65 (95.6%)  87 (94.6%)  .77  0.80 (0.19–3.48) 
Polymorphous vessels
Yes  8  7 (10.3%)  1 (1.1%)  .008  10.44 (1.25–87.02) 
No  152  61 (89.7%)  91 (98.9%)  .008  10.44 (1.25–87.02) 
Asymmetric periadnexal pigmentation
Yes  8  3 (4.4%)  5 (5.4%)  .77  0.80 (0.18–3.48) 
No  152  65 (95.6%)  87 (94.6%)  .77  0.80 (0.18–3.48) 
Chrysalis structures
Yes  7  2 (2.9%)  5 (5.4%)  .45  0.53 (0.10–2.80) 
No  153  66 (97.1%)  87 (94.6%)  .45  0.53 (0.10–2.80) 
Annular–granular structures
Yes  3  1 (1.5%)  2 (2.2%)  .75  0.67 (0.06–7.56) 
No  157  67 (98.5%)  90 (97.8%)  .75  0.67 (0.06–7.56) 
Parallel ridge pattern
Yes  2  0 (0%)  2 (2.2%)  .22  0 
No  158  68 (100%)  90 (97.8%)  .22  0 
Cumulative features
>2  46  27 (39.7%)  19 (20.7%)  .008  2.53 (1.26–5.10) 
0–2  114  41 (60.3%)  73 (79.4%)  .008  2.53 (1.26–5.10) 

Penultimate column: chi-square P values (P<.05 shown in bold).

Finally, Table 6 describes the clinical circumstances. Of note, 56% of cases were detected in a specialized pigmented-lesion clinic equipped with digital dermoscopy. The clinical setting was significantly associated with invasiveness, with in situ melanomas occurring more frequently among patients monitored using digital dermoscopy.

Table 6.

Clinical circumstances when excision was decided. Comparison of in situ and invasive melanomas (N=160).

Variable  Variable  Total  Invasores68 (42.5%)  In situ92 (57.5%)  P value 
Diagnostic suspicion of melanomaYes  110  52 (76.5%)  58 (63.1%)  .07 
No  50  16 (23.5%)  34 (36.9%)  .07 
Clinical setting of initial suspicionPatient  34  15 (22.06%)  19 (20.6%)  .02 
General dermatologist  36  22 (32.35%)  14 (15.2%)  .02 
Digital dermoscopy (during initial assessment or follow-up)  90  31 (45.59%)  59 (64.2%)  .02 
According to available imagesNo previous images  84  38 (55.9%)  46 (50.0%)  .41 
New lesion  21  11 (16.2%)  10 (10.9%)  .41 
Macroscopic change  26  10 (14.7%)  16 (17.4%)  .41 
Dermoscopic change only  29  9 (13.2%)  20 (21.7%)  .41 
Decision to exciseClinical findings only  6  4 (5.9%)  2 (2.2%)  .90 
Dermoscopy only  67  27 (39.7%)  40 (43.5%)  .90 
Clinical findings and dermoscopy  87  37 (54.4%)  50 (54.3%)  .90 
Discussion

This study analyzes the largest published series to date of SDMs evaluated by dermoscopy and confirms their limited clinical and dermoscopic expression, as reported in several former series.11,14,21,23,24,29,31 Comparison between studies is difficult because of methodological differences. We therefore focused this discussion on published series with ≥20 cases and sufficiently detailed descriptions of dermoscopic findings.11,13,14,23–32

Particularly noteworthy is that 42.5% of all our SDMs (and 43.1% of the 65 lesions measuring ≤4mm) were already invasive. This proportion varies widely across series11,13,14,23–32,40–42: among those providing detailed dermoscopic assessments, it ranges from 4%30 to 72.4%.27 Some of these invasive SDMs are metastatic,8,43 with nodular melanoma predominating among them43; this subtype often grows rapidly.6

The absence of a significant correlation between SDM diameter and invasiveness in our series (as also observed in series of larger melanomas44,45) suggests that some melanomas are biologically more aggressive from the outset, whereas others are destined to follow a more indolent course as in situ lesions until they reach diameters frequently exceeding 6mm.

Our findings highlight the limitations of the ABCDE rule for recognizing many SDMs, consistent with previous reports.13,14,32 The absence of an association between invasiveness and ABCDE-defined clinical atypia in this and other series39,46 also illustrates the limitations of clinical examination in determining whether a small suspicious lesion may already be invasive. Recognition of nodular SDMs poses a particular challenge because they commonly meet only the E criterion or none of the clinical ABCDE criteria.47 Indeed, one nodular melanoma in our series met none (Fig. 1C), and the other met only E. In our opinion, shared by other melanoma early-detection experts,48,49 every small, equivocal, palpable melanocytic lesion warrants particular caution and should preferably be excised in the absence of evidence confirming benignity.

The association of irregular borders (B) with invasiveness should be interpreted cautiously because nodular melanomas (usually more invasive and with regular borders)47 were probably underrepresented in our series: some may have been excised without specific suspicion of melanoma or photographic documentation. Conversely, the association of evolution (E) with invasiveness is consistent with findings in series not restricted by lesion size.39,50 Thus, a small, equivocal melanocytic lesion warrants particular caution when the patient reports recent changes.

SDMs predominate in younger adults: the mean age of our cohort (47.1 years) is approximately 10 years lower than that of patients with melanoma in our setting irrespective of lesion diameter.51,52 Their frequent occurrence on the extremities, particularly on women's legs, is also notable and has been described by other authors.13,53,54 We believe this finding indicates the patients in whom melanoma is most likely to be detected and excised while still small.

Although dermoscopic features are often subtle, some SDMs can be recognized readily by dermoscopy (Fig. 1F and H), which can also reveal key suspicious features in clinically unremarkable lesions (Fig. 1C and D).

The dermoscopic appearance of SDMs varies considerably across studies.11,13,14,23–32 Common suspicious global findings include those assessed here—asymmetry, multiple colors, and a high-risk global pattern (multicomponent, nonspecific, or spitzoid)—although a substantial proportion of tumors have only one or none of these signs,11,13,14,23–32 as in our study and in contrast to larger melanomas. Among local structures, irregular dots/globules and atypical pigment network were the most common in our series and are also frequent in other SDM series.11,13,14,23–32 Other features found relatively often in some but not all series include irregular pigmentation, irregular blotches, radial streaming, pseudopods, blue-white veil, and regression structures. Negative pigment network, shiny white lines/chrysalis structures, and atypical vascularization are less common. The low frequency of shiny white lines/chrysalis structures (4.4%) in our series does not appear attributable to nonpolarized dermoscopy, because only 12 cases (7.5%) were imaged without polarized light. We did not assess 2 dermoscopic structures described after our study design and case review began: angulated lines/polygons and superficial linear skin markings. Although one series of 26 cases found these in 46.2% and 11.5% of cases, respectively,26 other more recent and/or much larger series either detected none29 or very few.11,31

Quantifying the frequency of each dermoscopic structure helps establish what clinicians should look for and what can reasonably be expected in SDMs.11,13,14,23–32 However, assessing the tendency for suspicious global and local findings to accumulate, as we also did, more clearly reveals the diagnostic complexity. In our series, 49% of lesions displayed ≤1 global criterion and 71% displayed ≤2 local criteria, proportions similar to those seen in many atypical nevi. This explains why published algorithms perform less well for SDMs than for larger melanomas11,23,24,29,31,32 and confirms that most SDMs are difficult to detect dermoscopically, although views differ.20,25

Clinical atypia was not associated with invasiveness in our series, whereas dermoscopic atypia was. Specifically, invasiveness was associated with the accumulation of suspicious global or local dermoscopic melanoma features and with individual findings such as >2 colors, peripheral globules of any distribution pattern, blue-white veil, regression, and polymorphous vessels. Other authors have reported associations with invasiveness in SDMs for atypical vascular patterns, blue-gray structures, chrysalis structures, and negative pigment networks.11,31 When a small, equivocal nevus shows these signs, we recommend excision.

A striking finding was that all 3 melanomas with regularly arranged peripheral globules (in a ring) were invasive. Although a ring of peripheral globules is often seen in growing benign nevi, caution is necessary if the globules are irregular in morphology, color, or size; if the lesion displays any other central atypical feature; or if the finding occurs in middle-aged or older adults.37,38 Our study shows that, although uncommon, a regular ring of peripheral globules may accompany invasive SDM.

Of the melanomas in this series, 68.8% were excised with melanoma considered in the differential diagnosis. Dermoscopy was decisive in the decision to excise 96.3% of cases (in 87 cases together with clinical information), despite minimal clinical atypia and limited dermoscopic features in many lesions. In some instances, excision may have been based on evidence of evolution—the age at which a nevus appeared or changed—even in the absence of clear malignant features.55

Surveillance with total-body photography and digital dermoscopy facilitates detection of new or changing lesions.11,13,23,28,40,56,57 In our series, most melanomas detected in this way were in situ, and the clinical setting was associated with invasiveness. Clearly, more intensive surveillance11,13,23,28,40 makes it easier to identify new or unstable lesions while still small and noninvasive. Histologic diagnosis of in situ or thin melanoma leads to smaller final scars, but whether it reduces overall melanoma mortality remains debatable.58

Regarding potential overdiagnosis of melanomas that are histologically genuine but biologically harmless,58,59 we believe that restricting surgery to lesions>6mm, as proposed by some authors,58 is dangerous: many SDMs are already invasive and some metastasize.8,43 A more prudent strategy is to excise small suspicious lesions showing signs of invasiveness and consider monitoring selected lesions without such signs. Dermoscopy appears helpful in this task, as suggested by our results and those of other studies,11,31 provided it is not used to monitor palpable or nodular lesions of uncertain nature.48,49 Although digital dermoscopy may contribute in part to overdiagnosis,58 we believe it can also help address it,59 by avoiding excision of most flat atypical nevi that remain stable or grow slowly without developing further atypia.

Some SDM series evaluated by dermoscopy have also used reflectance confocal microscopy.13,23,25,30 This technique unquestionably increases diagnostic specificity.60 Moreover, recent research61 suggests that it may provide information about biological aggressiveness, potentially reducing overdiagnosis.62 It remains to be seen what artificial intelligence-based diagnostic support systems can offer,63 both for detecting SDMs and for identifying those that are biologically more aggressive and should always be excised. Recognizing the strengths and weaknesses of melanoma diagnostic strategies64 is essential to optimize outcomes for our patients.

Limitations

The main limitations are the retrospective design, heterogeneity of imaging equipment, and requirement for photographic documentation, which may have excluded unsuspected SDMs, particularly nodular melanomas.

Conclusions

Many SDMs are already invasive. They occur predominantly in younger adults and on the legs of women. The adapted clinical ABCDE rule (with D meaning dark pigmentation) has limitations in recognizing them or predicting invasiveness. SDMs are also challenging to detect by dermoscopy, although this technique reveals certain useful clues to potentially invasive lesions. More than half of the SDMs in this series were suspected among patients undergoing digital dermoscopic surveillance, with a significantly higher proportion of in situ lesions. Further studies and strategies are needed to facilitate early diagnosis while minimizing overdiagnosis.

Conflict of interest

The authors declare that they have no conflict of interest.

References
[1]
G.V. Long, S.M. Swetter, A.M. Menzies, J.E. Gershenwald, R.A. Scolyer.
Cutaneous melanoma.
[2]
R.J. Friedman, D.S. Rigel, A.W. Kopf.
Early detection of malignant melanoma: the role of physician examination and self-examination of the skin.
CA Cancer J Clin, 35 (1985), pp. 130-151
[3]
N.R. Abbasy, H.M. Shaw, D.S. Rigel, et al.
Early diagnosis of cutaneous melanoma. Revisiting the ABCDE criteria.
JAMA, 292 (2004), pp. 2771-2776
[4]
S.W. Menzies, I. Zalaudek.
Why perform dermoscopy? The evidence for its role in the routine management of pigmented skin lesions.
Arch Dermatol, 142 (2006), pp. 1211-1212
[5]
O. Yélamos, R.P. Braun, K. Liopyris, et al.
Usefulness of dermoscopy to improve the clinical and histopathologic diagnosis of skin cancers.
J Am Acad Dermatol, 80 (2019), pp. 365-377
[6]
L.J. Gardner, J.L. Strunk, Y.P. Wu, D. Grossman.
Current controversies in early-stage melanoma. Questions on incidence, screening, and histologic regression.
J Am Acad Dermatol, 80 (2019), pp. 1-12
[7]
G. Nazzaro, E. Passoni, F. Pozzessere, C.A. Maronese, A.V. Marzano.
Dermoscopy use leads to earlier cutaneous melanoma diagnosis in terms of invasiveness and size? A single-center, retrospective experience.
J Clin Med, 11 (2022), pp. 4912
[8]
H.M. Shaw, W.H. McCarthy.
Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia.
J Am Acad Dermatol, 27 (1992), pp. 679-682
[9]
E.M. Fernandez, K.S. Helm.
The diameter of melanomas.
Dermatol Surg, 30 (2004), pp. 1219-1222
[10]
A. Maley, A.R. Rhodes.
Cutaneous melanoma: preoperative tumor diameter in a general dermatology outpatient setting.
Dermatol Surg, 40 (2014), pp. 446-454
[11]
A. Regio Pereira, M. Corral-Forteza, H. Collgros, et al.
Dermoscopic features and screening strategies for the detection of small-diameter melanomas.
Clin Exp Dermatol, 47 (2022), pp. 932-941
[12]
H. Tsao, J.M. Olazagasti, K.M. Cordoro, et al.
Early detection of melanoma: reviewing the ABCDEs.
J Am Acad Dermatol, 72 (2015), pp. 717-723
[13]
C. Carrera, J. Palou, J. Malvehy, et al.
Early stages of melanoma on the limbs of high-risk patients: clinical, dermoscopic, reflectance confocal microscopy and histopathological characterization for improved recognition.
Acta Derm Venereol, 91 (2011), pp. 137-146
[14]
V. de Giorgi, I. Savarese, S. Rossari, et al.
Features of small melanocytic lesions: does small mean benign? A clinical-dermoscopic study.
Melanoma Res, 22 (2012), pp. 252-256
[15]
S.M. Goldsmith, A.R. Solomon.
A series of melanomas smaller than 4mm and implications for the ABCDE rule.
J Eur Acad Dermatol Venereol, 21 (2007), pp. 929-934
[16]
S.W. Menzies, J. Kreusch, K. Byth, et al.
Dermoscopic evaluation of amelanotic and hypomelanotic melanoma.
Arch Dermatol, 144 (2008), pp. 1120-1127
[17]
A. Niforou, D. Sgouros, A. Lallas, et al.
The spectrum of morphologic pattern of nodular melanoma: a study of the International Dermoscopy Society.
J Eur Acad Dermatol Venereol, 35 (2021), pp. e762-e765
[18]
G. Pellizzari, J. Magee, D. Weedon, C. Rosendahl.
A tiny invasive melanoma: a case report with dermoscopy and dermatopathology.
Dermatol Pract Concept, 3 (2013), pp. 6
[19]
B. Akay, A.O. Heper, S. Clark, C. Erdem, C. Rosendahl, H. Kittler.
Dermatoscopy of a melanoma less than one millimeter in diameter.
Int J Dermatol, 56 (2017), pp. 1498-1499
[20]
A. Bono, E. Tolomio, S. Trincone, et al.
Micro-melanoma detection: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter ≤3mm.
Br J Dermatol, 155 (2006), pp. 570-573
[21]
P. Carli, V. De Giorgi, A. Chiarugi, et al.
Effect of lesion size on the diagnostic performance of dermoscopy in melanoma detection.
Dermatology, 206 (2003), pp. 292-296
[22]
R.J. Friedman, D. Gutkowicz-Krusin, M.J. Farber, et al.
The diagnostic performance of expert dermatoscopists vs a computer-vision system on small-diameter melanomas.
Arch Dermatol, 144 (2008), pp. 476-482
[23]
C. Otero, S. Podlipnik, C. Carrera, et al.
Dermoscopic, confocal and histopathologic characteristics of small-diameter melanomas (minimelanomas): a cross sectional study.
Aust J Dermatol, 62 (2021), pp. 256-261
[24]
S. Seidenari, C. Ferrari, S. Borsari, et al.
Dermoscopy of small melanomas: just miniaturized dermoscopy?.
Br J Dermatol, 171 (2014), pp. 1006-1013
[25]
G. Pupelli, C. Longo, L. Veneziano, et al.
Small-diameter melanocytic lesions: morphological analysis by means of in vivo confocal microscopy.
Br J Dermatol, 168 (2013), pp. 1027-1033
[26]
A. Megaris, A. Lallas, L. Peruilh Bagolini, et al.
Dermoscopy features of melanomas with a diameter up to 5mm (micromelanomas): a retrospective study.
J Am Acad Dermatol, 83 (2020), pp. 1160-1161
[27]
N. Emiroglu, F. Pelin Cengiz, R. Hofmann-Wellenhof.
Dermoscopic and clinical features of trunk melanomas.
Postep Derm Alergol, 31 (2014), pp. 632-637
[28]
M.F. Vianna Hunziker, B. Martinez Zugaib Abdalla, F. Vieira Brandao, et al.
Exploring small-diameter melanomas: a retrospective study on clinical and dermoscopic features.
Life, 13 (2023), pp. 1907
[29]
M. Slowinska, G. Kaminska-Winziorek, E. Kowalska-Oledzka, et al.
Dermoscopy of small-diameter melanomas with the diagnostic feasibility of selected algorithms. A clinical retrospective multicenter study.
[30]
J.H. Pyne, S. McDonald, S.M. Beale, et al.
The hunt for baby melanomas: a prospective study of the dermoscopy features on 100 small melanoma cases with in vivo surface diameters up to a maximum of 6mm.
Dermatol Pract Concept, 12 (2022), pp. e2022197
[31]
G. Nazzaro, C.A. Maronese, G. Casazza, et al.
Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini-melanoma): a retrospective multicentric study of 269 cases.
Int J Dermatol, 62 (2023), pp. 1040-1049
[32]
G. Campos-do-Carmo, A. Brito Nobre, T. Cuzzi, G. Argenziano, C. Gil Ferreira, L.C. Santos Thuler.
Melanocytic lesions ≤6mm: prospective series of 481 melanocytic trunk and limb lesions in Brazil.
PLoS ONE, 16 (2021), pp. e0252162
[33]
E. Soura, P.J. Eliades, K. Shannon, A.J. Stratigos, H. Tsao.
Hereditary melanoma: update on syndromes and management. Genetics of familial atypical multiple mole melanoma syndrome.
J Am Acad Dermatol, 74 (2016), pp. 395-407
[34]
N. Jaimes, A.A. Marghoob.
The morphologic universe of melanoma.
Dermatol Clin, 31 (2013), pp. 599-613
[35]
H. Kittler, A.A. Marghoob, G. Argenziano, et al.
Standarization of terminology in dermoscopy/dermatoscopy: results of the third consensus conference of the International Society of Dermoscopy.
J Am Acad Dermatol, 74 (2016), pp. 1093-1106
[36]
N.M. Williams, K.D. Rojas, J.M. Reynolds, D. Kwon, J. Shum-Tien, N. Jaimes.
Assesment of diagnosis accuracy of dermoscopic structures and patterns used in melanoma detection. A systematic review and meta-analysis. JAMA Dermatol.
[37]
S. Cappilli, S. Rivero, L. Cornacchia, et al.
Melanocytic lesions with peripheral globules: proposal of an integrated management algorithm.
Dermatol Pract Concept, 13 (2023), pp. e2023010
[38]
O. Reiter, E. Chousakos, N. Kurtanski, et al.
Association between the dermoscopy morphology of peripheral globules and melanocytic lesion diagnosis.
J Eur Acad Dermatol Venereol, 35 (2021), pp. 892-899
[39]
A.F. Duarte, B. Sousa-Pinto, L.F. Azevedo, et al.
Clinical ABCDE rule for early melanoma detection.
Eur J Dermatol, 31 (2021), pp. 771-778
[40]
E.D. Drugge, E.R. Volpicelli, R.M. Sarac, S.R. Strang, D.M. Elston, R.J. Drugge.
Micromelanomas identified with time-lapse total body photography and dermoscopy.
J Am Acad Dermatol, 78 (2018), pp. 182-183
[41]
A. Bono, C. Bartolli, D. Moglia, A. Maurichi, T. Camerini, G. Grassi, et al.
Small melanomas: a clinical study on 270 consecutive cases of cutaneous melanoma.
Melanoma Res, 9 (1999), pp. 583-586
[42]
P. Vargas-Mora, R. González-Cuevas, L. Peruilh-Bagolini, F. Valenzuela.
Small-diameter melanomas (micromelanomas): clinical, dermoscopic and histopathological findings.
Anais Brasileiros Dermatol, 97 (2022), pp. 110-112
[43]
C. Dessinioti, M. Plaka, K. Kypreou, et al.
A retrospective study of small-diameter invasive melanomas: metastasis at diagnosis and 9-year follow-up.
J Am Acad Dermatol, 89 (2023), pp. 152-154
[44]
C. Dessinioti, M. Plaka, A. Befon, et al.
A retrospective study of diameter and Breslow thickness in invasive melanomas.
Dermatology, 240 (2024), pp. 462-467
[45]
E. Salijuma, J. Maskalane, K. Lallas, et al.
Poor correlation between diameter and Breslow thickness of melanoma.
J Eur Acad Dermatol Venereol, 38 (2024), pp. e56-e58
[46]
R. Liu, M. Pugliano-Mauro, T. Patton, L. Wang, N. Siripong, L.K. Ferris.
Re-evaluating the ABCD criteria using a consecutive series of melanomas.
J Am Acad Dermatol, 83 (2020), pp. 1161-1163
[47]
S. Kalkhoran, O. Milne, I. Zalaudek, et al.
Historical, clinical and dermoscopic characteristics of thin nodular melanoma.
Arch Dermatol, 146 (2010), pp. 311-318
[48]
E. Lallas, I. Zalaudek, Z. Apalla, et al.
Management rules to detect melanoma.
Dermatology, 226 (2013), pp. 52-60
[49]
G. Briatico, G. Brancaccio, C. Scharf, et al.
Indications for and contraindications to digital monitoring of patients with melanocytic lesions.
Dermatol Pract Concept, 14 (2024), pp. e2024200
[50]
P. Rosina, G. Tessari, M.V. Giordano, G. Girolomoni.
Clinical and diagnostic features of in situ melanoma and superficial spreading melanoma: a hospital based study.
J Eur Acad Dermatol Venereol, 26 (2012), pp. 153-158
[51]
D.M. Arranz-Sánchez, A. Pizarro, J.L. Valencia-Delfa, et al.
Características clínico-patológicas de los melanomas cutáneos diagnosticados en un hospital terciario mediterráneo entre 1990 y 2004: comparación entre sexos, por grupos de edad, y evolución a lo largo del tiempo.
Actas Dermosifiliogr, 100 (2009), pp. 476-485
[52]
J.A. Avilés-Izquierdo, P. Lázaro-Ochaita, R. Suárez-Fernández, I. Márquez-Rodas, V. Parra-Blanco, J.L. Escat-Cortés.
Cambios epidemiológicos en el melanoma cutáneo: estudio retrospectivo de 969 casos (1996–2010).
Rev Clin Esp, 213 (2013), pp. 81-87
[53]
E. Dika, M.A. Chessa, S. Ribero, et al.
Diagnostic efficacy of digital dermoscopy and clinical findings in thin melanoma of the lower limbs.
Acta Derm Venereol, 97 (2017), pp. 1100-1107
[54]
G. Salerni, C. Alonso, R. Fernández-Bussy.
A series of small-diameter melanomas on the legs: dermoscopic clues for early recognition.
Dermatol Pract Concept, 5 (2015), pp. 8
[55]
A. Pizarro, J.L. Santiago, D.I. Santiago.
Prevención y diagnóstico precoz del melanoma con dermatoscopia: una perspectiva biológica.
Actas Dermosifiliogr, 106 (2015), pp. 3-6
[56]
G. Salerni, T. Terán, C. Alonso, R. Fernández-Bussy.
The role of dermoscopy and digital dermoscopy in the clinical diagnosis of melanoma: clinical and dermoscopic features of 99 consecutive primary melanomas.
Dermatol Pract Concept, 4 (2014), pp. 7
[57]
S. Porcar Saura, A. March-Rodríguez, R.M. Pujol, S. Segura Tigell.
Seguimiento digitalizado combinado en población con alto riesgo de desarrollar un melanoma maligno: análisis retrospectivo de 152 pacientes.
Actas Dermosifiliogr, 112 (2021), pp. 250-256
[58]
H.G. Welch, B.L. Mazer, A.S. Adamson.
The rapid rise in cutaneous melanoma diagnoses.
N Engl J Med, 384 (2021), pp. 72-79
[59]
B. Betz-Stablein, H.P. Soyer.
Overdiagnosis in melanoma screening: is it a real problem?.
Dermatol Pract Concept, 13 (2023), pp. e2023247
[60]
C. Pezzini, S. Kaleci, J. Chester, F. Fametani, C. Longo, G. Pellacani.
Reflectance confocal microscopy diagnostic accuracy for malignant melanoma in different clinical settings: systematic review and meta-analysis.
J Eur Acad Dermatol Venereol, 34 (2020), pp. 2268-2279
[61]
A. Marconi, M. Quadri, F. Farnetani, et al.
In vivo melanoma cell morphology reflects molecular signature and tumor aggressiveness.
J Invest Dermatol, 142 (2022), pp. 2205-2216
[62]
K.J. Lee, M.S. Stark.
In vivo melanoma cell morphology and tumor aggressiveness: the promise of reflectance confocal microscopy in reducing unnecessary excisions.
J Invest Dermatol, 142 (2022), pp. 2053-2054
[63]
C.A. Primiero, G. Gargantini Rezze, L.J. Caffery, et al.
A narrative review: opportunities and challenges in artificial intelligence skin image analysis using total body photography.
J Invest Dermatol, 144 (2024), pp. 1200-1207
[64]
A.A. Marghoob, A. Scope.
The complexity of diagnosing melanoma.
J Invest Dermatol, 129 (2009), pp. 11-13
Copyright © 2026. AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas